<DOC>
	<DOC>NCT00857597</DOC>
	<brief_summary>The study objective is to evaluate the relative merits, safety and effectiveness of Transoral Incisionless Fundoplication (TIF) in GERD patients currently treated with daily Proton Pump Inhibitors (PPIs).</brief_summary>
	<brief_title>Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Age 1875 years Proven gastroesophageal reflux (pH &lt; 4 for &gt; 4.3% time while off PPIs for 714 days) On daily PPIs for &gt; 1 year Recurrence of GERD symptoms (GERDHRQL score difference of &gt; 10 between on and off PPIs) Normal or hypotonic LES resting pressure (540 mmHg) Patient willingness to cooperate with random group assignment, attend 45 office visits and comply with all tests in this protocol Signed informed consent BMI &gt; 35 Hiatal hernia &gt; 2 cm Esophagitis grade D Barrett's esophagus Esophageal stricture Esophageal ulcer Esophageal motility disorder Gastric motility disorder Prior splenectomy Gastric paralysis Pregnancy (in females) Immunosuppression ASA &gt; 2 Portal hypertension Coagulation disorders Previous antireflux procedure Any other health condition, which the investigator believes would prevent the patient from completing the study Lack of fluency in English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>GERD</keyword>
	<keyword>endoscopic</keyword>
	<keyword>fundoplication</keyword>
	<keyword>Proton Pump Inhibitors</keyword>
	<keyword>heartburn</keyword>
	<keyword>anti-reflux surgery</keyword>
</DOC>